Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of orbifloxacin in Korean Hanwoo cattle

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue 3, 2009, Pages 219-228

  Elias, G ^a   Lee, J S ^a   Hwang, M H ^a   Park, Y S ^b   Cho, K H ^b   Kim, Y H ^c   Park, S C ^a  

^a Kyungpook National University   (South Korea)

^b Gyeongsangbuk do Livestock Research Institute   (South Korea)

^c Gyeongbuk Veterinary Service Laboratory   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ORBIFLOXACIN;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CATTLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; ESCHERICHIA COLI; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KOREA; MANNHEIMIA HAEMOLYTICA; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; VALIDATION STUDY;

ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; ESCHERICHIA COLI; FEMALE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MANNHEIMIA HAEMOLYTICA; MICROBIAL SENSITIVITY TESTS; PROTEIN BINDING; SERUM BACTERICIDAL TEST; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); BOS; BOVINAE; ESCHERICHIA COLI; MANNHEIMIA HAEMOLYTICA; STAPHYLOCOCCUS AUREUS;

EID: 65949119114     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.01027.x     Document Type: Article

References (37)

1. Aliabadi, F.S. Lees, P. (2000) Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation. International Journal of Antimicrobial Agents, 14 (4 307 13. (Pubitemid 30224494)
2. Aliabadi, F.S. Lees, P. (2002) Pharmacokinetics and pharmacokinetic/ pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate. Journal of Veterinary Pharmacology and Therapeutics, 25, 161 174. (Pubitemid 34748190)
3. Aliabadi, F.S. Lees, P. (2003) Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf. Research in Veterinary Science, 74, 247 259. (Pubitemid 36622119)
4. Aliabadi, F.S., Ali, B.H., Landoni, M.F. Lees, P. (2003) Pharmacokinetics and PK/PD modeling of danofloxacin in camel serum and tissue cage fluids. Veterinary Journal, 165, 104 118. (Pubitemid 37555017)
5. Amsterdam, D. (1996) Susceptibility testing of antimicrobials in liquid media. In Antibiotics in Laboratory Medicine, 3rd edn. Ed. Lorian, V., pp. 53 105. Williams & Wilkins, Maryland.
6. Andrews, J.M. (2001) Determination of minimum inhibitory concentrations. Journal of Antimicrobial Chemotherapy, 48 (Suppl.s1 5 16. (Pubitemid 32684708)
7. Benet, L.Z. Hoener, B.A. (2002) Changes in protein binding has little clinical relevance. Clinical Pharmacology and Therapeutics, 71, 115 121. (Pubitemid 34271114)
8. Bergogne-Bérézin, E. (2002) Clinical role of protein binding of quinolones. Clinical Pharmacokinetics, 41, 741 750.
9. Burgess, D.S. (1999) Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance. Chest, 115, 19S 23S. (Pubitemid 29133432)
10. Davis, J.L., Papich, M.G. Weingarten, A. (2006) The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration. Journal of Veterinary Pharmacology and Therapeutics, 29, 191 197.
11. Dumka, V.K. Srivastava, A.K. (2006) Pharmacokinetics, urinary excretion and dosage regimen of levofloxacin following a single intramuscular administration in cross bred calves. Journal of Veterinary Science, 7, 333 337.
12. Engberg, J., Aarestrup, F.M., Taylor, D.E., Gerner-Smidt, P. Nachamkin, I. (2001) Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerging Infectious Diseases, 7, 24 34. (Pubitemid 32173330)
13. Gaur, A., Garg, S.K. Saini, S.P. (2005) Comparative disposition kinetics of ofloxacin following a single i.m. and s.c. administration in neonatal calves. Journal of Veterinary Pharmacology and Therapeutics, 28, 485 488. (Pubitemid 41530777)
14. Haines, G.R., Brown, M.P., Gronwall, R.R., Merritt, K.A. Baltzley, L.K. (2001) Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of mares. Canadian Journal of Veterinary Research, 65, 181 187. (Pubitemid 32758154)
15. Haritova, A.M., Rusenova, N.V., Paranov, P.R., Lashev, L.D. Fink-Gremmels, J. (2006) Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys. Veterinary Research Communications, 30, 775 789. (Pubitemid 44478712)
16. Heinen, E. (2002) Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration. Journal of Veterinary Pharmacology and Therapeutics, 25, 1 5. (Pubitemid 34592069)
17. Iherke, P.J., Papich, M.G. Demanuelle, T.C. (1999) The use of fluoroquinolones in veterinary dermatology. Veterinary Dermatology, 10, 193 204. (Pubitemid 129632880)
18. Liu, S., Zhang, L.W. Zhang, X.X. (2006) Interaction between fluoroquinolones and bovine serum albumin studied by affinity capillary electrophoresis. Analytical Sciences, 22, 1515 1518.
19. Marin, P., Escudero, E., Fernandez-Varon, E. Carceles, C.M. (2007a) Pharmacokinetics and milk penetration of orbifloxacin after intravenous, subcutaneous, and intramuscular administration to lactating goats. Journal of Dairy Science, 90, 4219 4225. (Pubitemid 350045198)
20. Marin, P., Fernandez-Varon, E., Escudero, E. Carceles, C.M. (2007b) Pharmacokinetic-pharmacodynamic integration of orbifloxacin in rabbits after intravenous, subcutaneous and intramuscular administration. Journal of Veterinary Pharmacology and Therapeutics, 31, 77 82.
21. Martinez, M., McDermott, P. Walker, R. (2006) Pharmacology of fluoroquinolones: a perspective for the use in domestic animals. Veterinary Journal, 172, 77 82. (Pubitemid 43869434)
22. Matsumoto, S., Nakai, M., Yoshida, M. Katae, H. (1998a) Absorption, distribution and excretion of orbifloxacin in swine and calves. Journal of the Japan Veterinary Medical Association, 51, 13 18. (In Japanese with English abstract).
23. Matsumoto, S., Takahashi, M., Kitadai, N. Katae, H. (1998b) A study of metabolites isolated from the urine samples of cats and dogs administered orbifloxacin. Journal of Veterinary Medical Science, 60, 1259 1261. (Pubitemid 128531602)
24. Matsumoto, S., Nakai, M., Yoshida, M. Katae, H. (1999) A study of metabolites isolated from urine samples of pigs and calves administered orbifloxacin. Journal of Veterinary Pharmacology and Therapeutics, 22, 286 289. (Pubitemid 29410453)
25. McKellar, Q., Gibson, I., Monteiro, A. Bregante, M. (1999) Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy, 43, 1988 1992. (Pubitemid 29395197)
26. Mckellar, Q.A., Sanchez Bruni, S.F. Jones, D.G. (2004) Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27, 503 514. (Pubitemid 39665136)
27. McKinnon, P.S. Davis, S.L. (2004) Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases. European Journal of Clinical Microbiology and Infectious Diseases, 23, 271 288. (Pubitemid 38669938)
28. Mueller, M., de la Pena, A. Derendorf, H. (2004) Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC. Antimicrobial Agents and Chemotherapy, 48, 369 377. (Pubitemid 38141689)
29. Nakamura, S. (1995) Veterinary use of new quinolones in Japan. Drugs, 49 (Suppl 2 152 158.
30. Orden Gutierrez, J.A. de la Fuente Lopez, R. (2001) Impact on public health of quinolone resistance in animal-origin bacteria. Revista Española de Salud Pública, 75, 313 320. (Pubitemid 32947608)
31. Papich, M.G. Riviere, J.E. (2001) Fluoroquinolone antimicrobial drugs. In Veterinary Pharmacology and Therapeutics, 8th edn. Ed. Adams, H.R., pp. 898 917. Iowa State Press, Ames, Iowa, USA.
32. Taha, A.A., Elsheikh, H.A., Khalafalla, A.E., Osman, I.A. Abdullah, A.S. (1999) Disposition kinetics of tylosin administered intravenously and intramuscularly in desert sheep and Nubian goats. Veterinary Journal, 158, 210 215.
33. Toutain, P.L. (2002) Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine. The AAPS Journal, 4 (4 E38.
34. Toutain, P.L. Bousquet-Mélou, A. (2002) Free drug fraction versus free drug concentration: a matter of frequent confusion. Journal of Veterinary Pharmacology and Therapeutics, 25, 460 463. (Pubitemid 36015656)
35. Toutain, P.L., Bousquet-Mélou, A. Martinez, M. (2007) AUC/MIC: a PK/PD index for antibiotics with time dimension or simply a dimensionless scoring factor? Journal of Antimicrobial Chemotherapy, 60, 1185 1188. (Pubitemid 350168312)
36. Wetzstein, H.G. (2005) Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance. Antimicrobial Agents and Chemotherapy, 49, 4166 4173. (Pubitemid 41400960)
37. Zeitlinger, M., Sauermann, R., Fille, M., Hausdorfer, J., Leitner, I. Müller, M. (2008) Plasma protein binding of fluoroquinolones affects antimicrobial activity. Journal of Antimicrobial Chemotherapy, 61, 561 567.